Response to comment on 'KRAS-mutated plasma DNA as predictor of outcome from irinotecan monotherapy in metastatic colorectal cancer'

^*Corresponding author for this work

Research output: Contribution to journal › Letter › peer-review

Access to Document

@article{a5172ff8d7ae45cdb492396926577f56,

title = "Response to comment on 'KRAS-mutated plasma DNA as predictor of outcome from irinotecan monotherapy in metastatic colorectal cancer'",

author = "Spindler, \{K. L.G.\} and N. Pallisgaard and Andersen, \{R. F.\} and A. Jakobsen",

year = "2014",

month = dec,

day = "9",

doi = "10.1038/bjc.2014.115",

language = "English",

volume = "111",

pages = "2380",

journal = "British Journal of Cancer",

issn = "0007-0920",

publisher = "Nature Publishing Group",

number = "12",

}

TY - JOUR

T1 - Response to comment on 'KRAS-mutated plasma DNA as predictor of outcome from irinotecan monotherapy in metastatic colorectal cancer'

AU - Spindler, K. L.G.

AU - Pallisgaard, N.

AU - Andersen, R. F.

AU - Jakobsen, A.

PY - 2014/12/9

Y1 - 2014/12/9

U2 - 10.1038/bjc.2014.115

DO - 10.1038/bjc.2014.115

M3 - Letter

C2 - 24619079

AN - SCOPUS:84927567995

SN - 0007-0920

VL - 111

SP - 2380

JO - British Journal of Cancer

JF - British Journal of Cancer

IS - 12

ER -